Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03871257
Title A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

malignant astrocytoma

brain glioma

optic nerve glioma

Therapies

Carboplatin + Vincristine Sulfate

Selumetinib

Age Groups: child | adult
Covered Countries USA | CAN


No variant requirements are available.